YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ghassan Abou-Alfa, MD/MBA
Memorial Sloan Kettering Cancer Center
Study Chair - Yun Yen, MD/PhD
Taipei Medical University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing You'An Hospital, Capital Medical University
Beijing, Beijing Municipality, China
- Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
- China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
- Foshan Hospital of Traditional Chinese Medicine
Foshan, Guangdong, China
- Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangzhou, Guangdong, China
- the First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
- Shenzhen People'S Hospital
Shenzhen, Guangdong, China
- the First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
- Hunan Cancer Hospital
Changsha, Hunan, China
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
- Shanghai Eastern Hepatobiliary Hospital
Shanghai, Shanghai Municipality, China
- Shanghai University of Traditional Chinese Medicine Shuguang Hospital
Shanghai, Shanghai Municipality, China
- Queen Mary Hospital
Hong Kong, Hong Kong
- China Medical University Hospital
Taichung, Taiwan
- National Cheng Kung University Hospital
Tainan, Taiwan
- Cancer Research Center, Taipei Municipal Wanfang Hospital
Taipei, Taiwan
- Taipei Medical University -Shuang Ho Hospital, Ministry of Health and Welfare
Taipei, Taiwan
- Taipei Medical University Cancer Center
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Chang Gung Memorial Hospital, Linkou
Taoyuan, Taiwan
- Calvin Pan. Md Gastroenterology & Hepatology Clinic
Flushing, New York, United States
- Northwell Monter Cancer Institute
Lake Success, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Jan 2020
- Primary completion
- 22 Mar 2024
- Completion
- 19 Nov 2024
- Last update posted
- 13 Apr 2025
- Registered enrollment
- 62
- Registry id
- NCT04000737
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.